NurExone Strengthens Path to Clinical Trials for ExoPTEN with New Manufacturing Process Validation

  • Company Is also Seeking Shareholder Approval of Amended and Restated Omnibus Plan Company Is also Seeking Shareholder Approval of Amended and Restated Omnibus Plan